The Patterns of Non-vitamin K Antagonist Oral Anticoagulants (NOACs) Use in Patients with Atrial Fibrillation in Seven Balkan Countries: a Report from the BALKAN-AF Survey
ConclusionsNOACs are increasingly used in AF patients in the Balkan Region, but NOAC use is predominantly guided by factors other than evidence-based decision-making (e.g., drug availability on the market or reimbursement policy). Efforts are needed to establish an evidence-based approach to OAC selection and to facilitate the optimal use of OAC, thus improving the outcomes in AF patients in this large region.
Source: Advances in Therapy - Category: Drugs & Pharmacology Source Type: research
More News: Albania Health | Atrial Fibrillation | Bleeding | Bosnia and Herzegovina Health | Bulgaria Health | Cancer & Oncology | Cardiology | Croatia Health | Drugs & Pharmacology | Heart | Heart Failure | Internal Medicine | Montenegro Health | Romania Health | Serbia Health | Stroke | Vitamin K | Vitamins